natl cons survey follow up letter

natl cons survey follow up letter.doc

National Consumer Surveys on Understanding the Risks and Benefits of FDA-Regulated Medical Products

natl cons survey follow up letter

OMB: 0910-0698

Document [doc]
Download: doc | pdf

DATE


Screening ID #

Resident

[STREET ADDRESS] [MULTI UNIT]

[CITY], [ST] [ZIP]


Dear [CITY] Resident:


I recently sent you a letter asking you to participate in an important survey being conducted for the U.S. Food and Drug Administration (FDA). This survey will help the FDA better understand how people think about communications related to the drugs, devices, and other medical products that it regulates. The response to the survey so far has been good, but we haven’t heard from you and still need your views to help represent the opinions of people in the [CITY] area.


Please call 1-XXX-XXX-XXXX to participate in the survey before [DUE DATE]. It will only take about 15 minutes of your time. Your phone number will NOT be used for any other purpose than this study. It will not be sold or shared, and it will be deleted after the study is finished in 2012.


If you decide to participate, your identity and responses will be kept completely private. We are required by Federal law to keep the study information secure, and we have taken steps to make sure we carefully protect your information. We will not release your information to anyone not involved with the study. No individual information will be reported back to the FDA or any other individual, agency or organization.


RTI International, a non-profit research company, is conducting this survey for FDA. If you have any questions about the study, you may contact a study team member toll-free at
1-XXX-XXX-XXXX.


Your help is extremely important to the success of this study. Thank you in advance for your cooperation.


Sincerely,




FDA Official TBD

File Typeapplication/msword
File TitleLETTERHEAD HERE: RTI
AuthorYChiang
Last Modified Byjcapezzu
File Modified2011-06-16
File Created2011-06-16

© 2024 OMB.report | Privacy Policy